Showing 17,541 - 17,560 results of 31,626 for search '(( a step decrease ) OR ( 50 ((((ng decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.12s Refine Results
  1. 17541

    Table_2_The Effect of Clostridium butyricum on Gut Microbiota, Immune Response and Intestinal Barrier Function During the Development of Necrotic Enteritis in Chickens.DOCX by Ting Huang (190932)

    Published 2019
    “…At day 20, the chickens were divided into four groups: C. perfringens challenged and unchallenged chickens with and without C. butyricum supplementation. All groups were fed a basal diet for 13 days and thereafter a basal diet with 50% fishmeal from day 14 to 24. …”
  2. 17542

    Data_Sheet_1_Monounsaturated and polyunsaturated fatty acids concerning prediabetes and type 2 diabetes mellitus risk among participants in the National Health and Nutrition Examin... by Susu Jiang (9240579)

    Published 2023
    “…However, this protective effect may decrease with age. Moreover, the effects of the specific UFA on prediabetes and T2DM need further consideration.…”
  3. 17543

    DataSheet_1_The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass.docx by Tuo Pan (9264234)

    Published 2023
    “…Secondly, a propensity-score matched cohort (sivelestat vs control: 50 vs 50) was performed in these 665 patients. …”
  4. 17544

    Image1_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  5. 17545

    Image4_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  6. 17546

    Image2_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  7. 17547

    Image5_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  8. 17548

    DataSheet1_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  9. 17549

    DataSheet_1_The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass.docx by Tuo Pan (9264234)

    Published 2023
    “…Secondly, a propensity-score matched cohort (sivelestat vs control: 50 vs 50) was performed in these 665 patients. …”
  10. 17550

    Image3_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  11. 17551

    Sample gallery of the spatial nuclear patterns produced in Filter 1. by Angelika Manhart (1379565)

    Published 2018
    “…For each force combination, we show predicted patterns in a narrow (VL4) and wide (VL3) cell (black rectangles). …”
  12. 17552

    sFRP-3 binds EGF <i>in vitro</i>. by Raffaella Scardigli (49421)

    Published 2008
    “…Absorbance scanning from emission value 505 nm to 540 nm of EGFAlexa488 (green curve). A decreasing of the emission peak (517 nm) is shown in relation to EGFAlexa488/sFRP-3 interaction (red curve). …”
  13. 17553

    DataSheet_2_IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.docx by Hortensia Álvarez (830316)

    Published 2023
    “…All of them matched their counterparts several months following ART initiation. MIG levels showed a greater decrease at day 10 in those treated with INSTI (p=0·038). …”
  14. 17554

    Metabolically healthy obesity and depressive symptoms: 16-year follow-up of the Gazel cohort study by Guy-Marino Hinnouho (3909874)

    Published 2017
    “…<div><p>Aims</p><p>The health correlates of the metabolically healthy obese (MHO) phenotype, particularly in relation to depressive symptoms remains unclear. Accordingly, we examined the risk of depressive symptoms in this phenotype using a 16-year follow-up prospective study.…”
  15. 17555

    Table_1_Implication of Non-electrostatic Contribution to Deionization in Flow-Electrode CDI: Case Study of Nitrate Removal From Contaminated Source Waters.DOCX by Jingke Song (526928)

    Published 2019
    “…Through periodic replacement of the electrolyte at a water recovery of 91.4%, we show that the FCDI system can achieve a continuous desalting performance with the effluent NO<sub>3</sub>-N concentration below 1 mg NO<sub>3</sub>-N L<sup>−1</sup> at low energy consumption (~0.5 kWh m<sup>−3</sup>) but high productivity.…”
  16. 17556

    Supplementary Material for: Calcium-Alkali Syndrome Associated with Hypoparathyroidism Following Total Thyroidectomy by Kuroya S. (8343321)

    Published 2020
    “…All patients received calcium lactate and alfacalcidol for postsurgical hypocalcemia. We defined hypercalcemia as a corrected serum calcium level (cCa) ≥10.5 mg/dL, metabolic alkalosis as a difference in serum sodium and serum chloride ([sNa-sCl]) ≥39 mEq/L, and renal impairment as a50% increase in serum creatine and/or ≥35% decrease in estimated glomerular filtration rate (eGFR) compared to baseline. …”
  17. 17557

    DataSheet_1_IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.zip by Hortensia Álvarez (830316)

    Published 2023
    “…All of them matched their counterparts several months following ART initiation. MIG levels showed a greater decrease at day 10 in those treated with INSTI (p=0·038). …”
  18. 17558

    Viral Inhibition of Bacterial Phagocytosis by Human Macrophages: Redundant Role of CD36 by Grace E. Cooper (3193272)

    Published 2016
    “…Concurrently, there was a significant increase in IFNβ gene expression in response to infection and we observed a significant decrease in bacterial phagocytosis (p = 0.031) and CD36 gene expression (p = 0.031) by MDM cultured for 24 h in 50IU/ml IFNβ. …”
  19. 17559

    Hepatoprotective and antioxidant effect of ellagitannins and galloyl esters isolated from <i>Melaleuca styphelioides</i> on carbon tetrachloride-induced hepatotoxicity in HepG2 cel... by Eman Al-Sayed (2934060)

    Published 2016
    “…(Myrtaceae) showed a significant hepatoprotective effect in a CCl<sub>4</sub>-induced toxicity model in mice. …”
  20. 17560

    Effects of MBHA3 treatment on the acidic compartments of T. cruzi. by Jana M. Sandes (548760)

    Published 2014
    “…Nevertheless, in cells treated with the 4x IC<sub>50</sub> of MBHA3, a striking decrease of the fluorescent signal from red channel was observed. …”